HEMATOLOGY
FANER, Ned Denebe
LACANILAO, Sunshine
NUCUM, Billie Kim
PAGADUAN, Maribec
PUA, Monalisa
BLOOD
Small
Monocyte lymphocyte
Platelets Neutrophil
Small Eosinophil
lymphocyte
Erythrocyte
Neutrophil
Young (band)
Large neutrophil
Lymphocyte Monocyte
Neutrophil
Basophil
Red Blood Cells
small,biconcave disks that lack a nucleus
when mature. 4 to 6 million red blood cells
per mm3 of whole blood.
Red blood cells transport oxygen, and
each contains about 200 million molecules
of hemoglobin, the respiratory pigment.
Make ATP by anaerobic metabolism
HEMOGLOBIN
The cytoplasm of an RBC consists mainly of a
33%solution of hemoglobin (Hb), the red pigment
that gives the RBC its color and name.
lungs
Hb + O2 HbO2
tissues
HEMOGLOBIN
Hemoglobin consists of four protein
chains.
Each chain is
conjugated with a
β α nonprotein moiety
called the heme
group, which binds
oxygen to a ferrous
α β ion
(Fe2) at its center
Hypoxemia RBC PRODUCTION AND
(inadequate O2 transport REGULATION
Sensed by The kidneys release
liver and Increased increased
kidneys O2 transport amounts of
erythropoietin whenever
the oxygen capacity of
the blood is
reduced. Erythropoietin
stimulates the red bone
Secretion of Increased marrow to speed up its
erythropoietin RBC count production of red blood
cells, which carry
oxygen. Once the
oxygen-carrying
Accelerated capacity of the blood is
erythropoiesis sufficient to support
normal cellular activity,
the
kidneys cut back on their
Stimulation of production of
red bone marrow erythropoietin.
ANEMIA Impaired erythropoietin production
Decreased
Impaired cellular response to
erythropoietin erythropoietin (e.g. anemia of
effect
chronic diseases)
↓ proliferation
By external agents, physical or
chemical (e.g. ionizing radiation,
marrow toxins
Marrow
damage Hereditary or acquired aplastic
or defect anemia
Intrinsic marrow replacement
(e.g. myelofibrosis
ANEMIA
Megaloblastic Vit B12 deficiency
macrocytic Folate deficiency
Maturation
defect
Iron deficiency and the
anemia of chronic disease
Microcytic
Impaired globin chain
(hypochromic synthesis
(thalassemias)
Impaired porphyrin
synthesis
ANEMIA Membrane defects (e.g.
hereditary
Phagocytosis by spherocytosis)
reticuloendothelial
cells Heinz body associate
(e.g. G6PD deficiency)
Hemoglobin discorders
(e.g. sickle cell)
Accelerated Red cell
fragmentation DIC
Hemolysis
syndromes Vasculitis
syndromes
Sickle cell
Intravascular Osmotic and
hemolysis physical injury
ANEMIAS
Type Morphologic Causes Underlying
characteristics Pathophysiology
Microcytic: Microcytic; Inadequate Insufficient iron stores lead to
Iron hypochromic diet a depleted RBC mass with
deficiency; Blood loss, subnormal hgb conc, and in
chronic blood chronic turn, subnormal O2 carrying
loss capacity of the blood
Macrocytic or Macrocytic with Inadequate Vit B12 deficiency Inhibits
megaloblastic; variation in size, diet, lack of cell growth; deformed RBCs
pernicious or shape of RBCs intrinsic with poor O2 carrying capacity
folic acid factor for Neuro damage occurs bec
pernicious VB12 impairs myelin formation
anemia, Deficiency of folic acid results
impaired in inhibits cell growth, which
absorption have shortened life span
ANEMIAS
Type Morphologic Causes Underlying
Characteristics Pathophysiology
Aplastic Normocytic, drug toxicity, Damage of
normochromic RBCs, genetic failure, destroyed stem cells
depletion of radiation, inhibit blood cell
leukocytes and chemicals, production
platelets infections
Hemolytic Normocytic, Mechanical injury, Reduced RBC
normochromic, inc RBC antigen- survival
number of antibody reaction,
reticulocytes chemical reactions
Post Normocytic, Internal or external Reduced circulating
hemorrhagic; normochromic, inc hemorrhage blood volume
acute number of
hemorrhage reticulocytes within
48-72 h
POLYCYTHEMIA VERA
Uncontrolled and rapid cellular
reproduction and maturation cause
proliferation or hyperplasia of all bone
marrow cells (panmyelosis)
↑ RBC mass, ↑ blood viscosity, inhibits
blood flow to microcirculation
↓ blood flow and thrombocytosis set the
stage for intravascular thrombosis
SICKLE CELL
ANEMIA
OVERVIEW
Sickle-cell disease is a general term for a
group of genetic disorders caused by
sickle hemoglobin (Hgb S or Hb S).
Erythrocytes become elongated and
crescent shaped (sickled)
removed from the circulation and destroyed at
increased rates, leading to anemia.
OVERVIEW
An autosomal
recessive inherited
defect
The disease is
chronic and lifelong.
Lifespan is often
shortened with
sufferers living to an
average of 40 years.
OVERVIEW
The polymerization of deoxygenated HbS is the
primary indispensable event in the molecular
pathogenesis of sickle cell disease
HbS polymerization is associated with increased
red cell density (dense erythrocytes) as well as
red cell membrane damage favoring the
generation of distorted rigid sickle cells and
contributing to vaso-occlusion and premature
red cell destruction (hemolytic anemia).
OVERVIEW
The gene defect is a known mutation of a
single nucleotide polymorphism (SNP) (A
to T) of the β-globin gene, which results in
glutamic acid to be substituted by valine at
position 6.
GAG to GUG codon mutation = LEADING
TO HbS FORMATION
OVERVIEW
Fetal hemoglobin contains a gamma, not a
beta chain, the disease usually will not
result in clinical symptoms until the child’s
hemoglobin changes from the fetal to the
adult form at approximately 6 months.
Sickle-Cell Trait
Both parents with the disease will have
both normal adult and hemoglobin S and
be carriers (heterozygous) of the SICKLE-
CELL TRAIT.
25% - 50% of hemoglobin is abnormal.
No symptoms
Diagnosis
Can be diagnose prenatally by chorionic villi
sampling or from cord blood during
amniocentesis
Attacks are diagnosed clinically
Abnormal hemoglobin forms are detected on
hemoglobin electrophoresis, a form of gel
electrophoresis on which the various types of
hemoglobin move at varying speed
sickledex
Characteristics of Sickled Cells
Normal RBC Sickled
Cells
120-day life span 30- to 40- day
life span
Hgb has normal Hb has
O2 carrying decreased O2
capacity carrying
capacity
12 to 14 g/ml of 6 to 9 g/ml of Hb
Hb
RBC destroyed at RBCs destroyed at
accelerated rate
CRISES
1. Vaso-occlusive— “painful episode”
2. Acute splenic sequestration-- pooling of blood
3. Aplastic– diminished RBC production
4. Hyperhemolytic– accelerated rate of RBC
destruction
5. Cerebrovascular accident– blockage of major
blood vessels
6. Acute Chest syndrome– similar to pneumonia
7. Infection
Change in one base-pair in DNA molecule
Valine produced instead of glutamic
acid at position, 6 in β-chain
Desctruction Abnormal hemoglobin molecule Concentration
of many of sickle-
sickle cells shaped cells in
Sickling of RBC the spleen
Clumping of sickle shaped cells
Enlargement
Anemia interferes with circulation
of spleen
Proliferation Impaired blood supply to
of bone Enlargement various organs Fibrosis of
marrow of heart spleen
Weakness Slowed
and physical Damage Damge Damage Brain Damage
lassitude development to heart to lungs to damage to abd Kidney
muscle muscles organs damage
Impaired and
mental joints
function
Heart pneumonia paralysis Kidney
Abd
Failure Rheumatism pain failure
DEATH
NURSING PROBLEMS
Impaired gas Ineffective tissue
exchange perfusion
Dyspnea paralysis
Use of accessory Tissue infarction
muscle Bone pain
Cyanosis
Hypoxia
restlessness
NURSING PROBLEMS
Acute/ Chronic pain • Delayed growth
Localized/ and development
generalized joint and/
-Altered physical
or abdominal/ back
growth
pain
Guarding -Delay and difficulty
Crying, restlessness performing skills
Facial grimacing
Sickle cell anemia as an
inflammatory disease
Orah S. Platt
Harvard Medical School, Children’s Hospital,
300 Longwood Avenue, Boston,
Massachusetts 02115, USA.
Sickle cell anemia as an inflammatory
disease
Classical view---“primary genetic defect”:
abnormal Hgb
Holistic view---abnormal hgb interacts with,
damages, and stimulates the vascular
endothelium “irritant”
“. . .reperfusion injury plays a major role
in sickle pathophysiology. . .”
Sickle cell anemia as an inflammatory
disease
high base-line leukocyte count
ongoing base-line chronic inflammation
major risk factor for severity in sickle cell
anemia
References
Andreoli & Bennett etal; Cecil Essential of Medicine, 4th Edition,
1997, WB Saunders Co
Bullock: Pathophysiolgy: Adaptations and Alterations in Function, 4th
Edition; 1996, Lippincott
Fauci et al: Harrison’s Principle of Internal Medicine, 17th Edition:
McGraw Hill Companies, Inc
Mader: Understanding Human Anatomy Physiology, Fifth Edition,
The McGraw−Hill Companies, 2004
Marieb: Essentials of Human Anatomy and Physiology, 6th Edition,
2002, Pearson Education Asia Pte, Ltd
McPhee at al: Pathophysiology: An Introduction to Clinical Medicine,
2nd Edition, 1997, Prentice Hall, ltd
Rifknd et al: Fundamentals of Hematology, 2nd Edition; 1980; Year
Book Medical Publishers, Inc
Straight A’s in Pathophysiology: A Review Series; Lippincott Williams
& Wilkins